Table 3.
Serotonin (ng/mL) | CTX-1 (pg/mL) | DYP (nmol/L) | PYD (ng/mL) | |
---|---|---|---|---|
Sham | 200.10 ± 28.19 | 167.10 ± 14.10 | 2.10 ± 0.10 | 27.07 ± 0.97 |
OVX | 390.20 ± 67.26∗ | 155.5 ± 8.14 | 3.07 ± 0.18∗∗∗ | 34.92 ± 3.20∗ |
PE-25 | 264.30 ± 38.04 | 106.80 ± 7.95## | 2.37 ± 0.07### | 27.47 ± 1.51# |
PE-100 | 205.70 ± 22.92# | 110.60 ± 7.14# | 2.23 ± 0.12#### | 25.86 ± 1.42## |
PE-400 | 222.60 ± 40.00# | 104.10 ± 11.25## | 2.34 ± 0.08### | 25.18 ± 1.06### |
PE-1600 | 159.40 ± 45.05## | 96.24 ± 9.87### | 2.09 ± 0.10#### | 25.31 ± 0.88## |
Data are presented as the mean ± standard error of mean (SEM). Sham, sham operation; OVX, ovariectomy; PE-25, OVX + PE 25 mg/kg; PE-100, OVX + PE 100 mg/kg; PE-400, OVX + PE 400 mg/kg; PE-1600, OVX + PE 1600 mg/kg; CTX-1, C-terminal telopeptide fragment of type I collagen; DYP, deoxypyridinoline; PYD, pyridinoline. ∗p < 0.05 and ∗∗∗p < 0.001vs. sham group; #p < 0.05, ##p < 0.01, ###p < 0.001, and ###p < 0.0001vs. OVX group.